Accumulating evidence has demonstrated the important role of high EZH2 expression in the malignant progression of epithelial ovarian cancer (23, 24), but the underlying regulatory mechanism remains largely unknown and warrants further investigation. This evidence concerns the gene EZH2 and ovarian carcinoma.